{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:49:01Z","timestamp":1791823741657,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7242229"],"award-info":[{"award-number":["7242229"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"DOI":"10.1007\/s10067-026-08430-2","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T01:08:59Z","timestamp":1791767339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics and associated factors of difficult-to-treat rheumatoid arthritis: a cross-sectional study"],"prefix":"10.1007","author":[{"given":"Xiaojun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangliang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-6849","authenticated-orcid":false,"given":"Xiujuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"8430_CR1","unstructured":"National Clinical Research Center for Dermatologic and Immunologic Diseases (Peking Union Medical College Hospital), Rheumatology Physician Branch of Chinese Medical Doctor Association, Rheumatology and Immunology Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, et al (2024) Chinese Guideline for the Diagnosis and Treatment of Rheumatoid Arthritis. Chinese J Int Med 63(11): 1059\u20131077"},{"issue":"11","key":"8430_CR2","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","volume":"78","author":"S Safiri","year":"2019","unstructured":"Safiri S, Kolahi AA, Hoy D et al (2019) Global, regional and national burden of rheumatoid arthritis 1990\u20132017: a systematic analysis of the Global Burden of Disease study 2017. Ann Rheum Dis 78(11):1463\u20131471","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"8430_CR3","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s10067-024-07083-3","volume":"43","author":"H Gu","year":"2024","unstructured":"Gu H, Yan D, Li J et al (2024) Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data. Clin Rheumatol 43(9):2799\u20132806","journal-title":"Clin Rheumatol"},{"issue":"5","key":"8430_CR4","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/rheumatology\/keac584","volume":"62","author":"M Dey","year":"2023","unstructured":"Dey M, Nagy G, Nikiphorou E (2023) Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin? Rheumatology (Oxford) 62(5):1773\u20131779","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8430_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","volume":"80","author":"G Nagy","year":"2021","unstructured":"Nagy G, Roodenrijs N, Welsing PM et al (2021) EULAR definition of difficult-to-treat rheumatoid arthritis. Ann Rheum Dis 80(1):31\u201335","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8430_CR6","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1093\/rheumatology\/keaa860","volume":"60","author":"N Roodenrijs","year":"2021","unstructured":"Roodenrijs N, van der Goes MC, Welsing P et al (2021) Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology (Oxford) 60(8):3778\u20133788","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"8430_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/25785826.2021.1928383","volume":"45","author":"R Watanabe","year":"2022","unstructured":"Watanabe R, Hashimoto M, Murata K et al (2022) Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort. Immunol Med 45(1):35\u201344","journal-title":"Immunol Med"},{"issue":"9","key":"8430_CR8","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1093\/rheumatology\/keae265","volume":"63","author":"R Watanabe","year":"2024","unstructured":"Watanabe R, Ebina K, Gon T et al (2024) Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study. Rheumatology (Oxford) 63(9):2418\u20132426","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8430_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/rheumatology\/keae318","volume":"64","author":"ML Paudel","year":"2025","unstructured":"Paudel ML, Li R, Naik C et al (2025) Prevalence and characteristics of adults with difficult-to-treat rheumatoid arthritis in a large patient registry. Rheumatology (Oxford) 64(3):1102\u20131110","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"8430_CR10","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/rheumatology\/keac563","volume":"62","author":"A Giollo","year":"2023","unstructured":"Giollo A, Zen M, Larosa M et al (2023) Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study. Rheumatology (Oxford) 62(6):2083\u20132089","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8430_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/03009742.2023.2277542","volume":"53","author":"T Michitsuji","year":"2024","unstructured":"Michitsuji T, Fukui S, Morimoto S et al (2024) Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: a multicenter RA ultrasound cohort study. Scand J Rheumatol 53(2):123\u2013129","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"8430_CR12","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"8430_CR13","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1007\/s10067-021-05687-7","volume":"40","author":"H Li","year":"2021","unstructured":"Li H, Zhu H, Xu L et al (2021) The characteristics and its contributing factors of refractory rheumatoid arthritis, view of the rheumatologists of China: results of a nationwide cross-sectional survey. Clin Rheumatol 40(10):4029\u20134038","journal-title":"Clin Rheumatol"},{"key":"8430_CR14","doi-asserted-by":"publisher","first-page":"1353964","DOI":"10.3389\/fnut.2024.1353964","volume":"11","author":"Z Lu","year":"2024","unstructured":"Lu Z, Xie Z, Shen K et al (2024) Association of dietary inflammatory index with immune-inflammatory biomarkers in rheumatoid arthritis patients: results from NHANES 1999\u20132018. Front Nutr 11:1353964","journal-title":"Front Nutr"},{"issue":"1","key":"8430_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13075-023-03018-6","volume":"25","author":"B Liu","year":"2023","unstructured":"Liu B, Wang J, Li YY et al (2023) The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999\u20132018. Arthritis Res Ther 25(1):34","journal-title":"Arthritis Res Ther"},{"key":"8430_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1309835","volume":"14","author":"E Zhou","year":"1999","unstructured":"Zhou E, Wu J, Zhou X et al (1999) The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among U.S. adults with rheumatoid arthritis: results from NHANES 1999-2020. Front Immunol 14:1309835","journal-title":"Front Immunol"},{"issue":"4","key":"8430_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/art.42767","volume":"76","author":"P David","year":"2024","unstructured":"David P, Di Matteo A, Hen O et al (2024) Poly-refractory rheumatoid arthritis: an uncommon subset of difficult to treat disease with distinct inflammatory and noninflammatory phenotypes. Arthritis Rheumatol 76(4):510\u2013521","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8430_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-023-03165-w","volume":"25","author":"JY Jung","year":"2023","unstructured":"Jung JY, Lee E, Kim JW et al (2023) Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry. Arthritis Res Ther 25(1):174","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"8430_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002842","volume":"9","author":"L Leon","year":"2023","unstructured":"Leon L, Madrid-Garcia A, Lopez-Viejo P et al (2023) Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease. RMD Open 9(1):e002842","journal-title":"RMD Open"},{"key":"8430_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae325","author":"S Takanashi","year":"2024","unstructured":"Takanashi S, Takeuchi T, Kaneko Y (2024) Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keae325","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8430_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11926-023-01117-6","volume":"25","author":"C Conran","year":"2023","unstructured":"Conran C, Kolfenbach J, Kuhn K et al (2023) A review of difficult-to-treat rheumatoid arthritis: definition, clinical presentation, and management. Curr Rheumatol Rep 25(12):285\u2013294","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"8430_CR22","first-page":"1135","volume":"57","author":"M de Hair","year":"2018","unstructured":"de Hair M, Jacobs J, Schoneveld J et al (2018) Difficult-to-treat rheumatoid arthritis: an areaof unmet clinical need. Rheumatology (Oxford) 57(7):1135\u20131144","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"8430_CR23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1136\/annrheumdis-2018-213378","volume":"77","author":"L Kearsley-Fleet","year":"2018","unstructured":"Kearsley-Fleet L, Davies R, De Cock D et al (2018) Biologic refractory disease in rheumatoidarthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Ann Rheum Dis 77(10):1405\u20131412","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8430_CR24","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1093\/rheumatology\/keab209","volume":"60","author":"S Takanashi","year":"2021","unstructured":"Takanashi S, Kaneko Y, Takeuchi T (2021) Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice. Rheumatology (Oxford) 60(11):5247\u20135256","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"8430_CR25","first-page":"654","volume":"43","author":"H Li","year":"2023","unstructured":"Li H, Yang R (2023) Immunomodulatory functions of platelets and their roles in related diseases. Chin J Microbiol Immunol 43(9):654\u2013662","journal-title":"Chin J Microbiol Immunol"},{"issue":"8","key":"8430_CR26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00296-019-04337-1","volume":"39","author":"B Michael","year":"2019","unstructured":"Michael B, Kommoju V, Kavadichanda GC et al (2019) Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis. Rheumatol Int 39(8):1377\u20131387","journal-title":"Rheumatol Int"},{"issue":"01","key":"8430_CR27","first-page":"64","volume":"27","author":"Y Liu","year":"2015","unstructured":"Liu Y, Li Z, Geng L et al (2015) Correlation between platelet parameters and immunoinflammatory markers in rheumatoid arthritis and their clinical significance. Med J Chinese People\u2019s Liberation Army 27(01):64\u201368","journal-title":"Med J Chinese People's Liberation Army"},{"key":"8430_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1204652","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Jiang H, Kang T et al (2023) Platelets-related signature based diagnostic model in rheumatoid arthritis using WGCNA and machine learning. Front Immunol 14:1204652","journal-title":"Front Immunol"},{"issue":"10","key":"8430_CR29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/ard-2023-225414","volume":"83","author":"C Baerwald","year":"2024","unstructured":"Baerwald C, Stemmler E, Gn\u00fcchtel S et al (2024) Predictors for severe persisting pain in rheumatoid arthritis are associated with pain origin and appraisal of pain. Ann Rheum Dis 83(10):1381\u20131388","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8430_CR30","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/art.41440","volume":"72","author":"AC Heisler","year":"2020","unstructured":"Heisler AC, Song J, Muhammad LN et al (2020) Association of dysregulated central pain processing and response to disease-modifying antirheumatic drug therapy in rheumatoid arthritis. Arthritis Rheumatol 72(12):2017\u20132024","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"8430_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3899\/jrheum.220500","volume":"50","author":"A Wohlfahrt","year":"2023","unstructured":"Wohlfahrt A, Muhammad LN, Song J et al (2023) Pain mechanisms associated with disease activity in patients with rheumatoid arthritis treated with disease-modifying antirheumatic drugs: a regression tree analysis. J Rheumatol 50(6):741\u2013747","journal-title":"J Rheumatol"},{"issue":"10","key":"8430_CR32","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/ejp.1651","volume":"24","author":"P Vergne-Salle","year":"2020","unstructured":"Vergne-Salle P, Pouplin S, Trouvin AP et al (2020) The burden of pain in rheumatoid arthritis: impact of disease activity and psychological factors. Eur J Pain 24(10):1979\u20131989","journal-title":"Eur J Pain"},{"issue":"5","key":"8430_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/1744666X.2019.1573675","volume":"15","author":"M Harth","year":"2019","unstructured":"Harth M, Nielson WR (2019) Pain and affective distress in arthritis: relationship to immunity and inflammation. Expert Rev Clin Immunol 15(5):541\u2013552","journal-title":"Expert Rev Clin Immunol"},{"key":"8430_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221124028","volume":"14","author":"M Novella-Navarro","year":"2022","unstructured":"Novella-Navarro M, Benavent D, Ruiz-Esquide V et al (2022) Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis. Ther Adv Musculoskelet Dis 14:1759720X-221124028X","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"8430_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s42358-024-00396-6","volume":"64","author":"W Qi","year":"2024","unstructured":"Qi W, Robert A, Singbo N et al (2024) Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study. Adv Rheumatol 64(1):55","journal-title":"Adv Rheumatol"},{"issue":"1","key":"8430_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13075-024-03431-5","volume":"26","author":"B D'Onofrio","year":"2024","unstructured":"D\u2019Onofrio B, De Stefano L, Bozzalla CE et al (2024) Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat. Arthritis Res Ther 26(1):192","journal-title":"Arthritis Res Ther"},{"key":"8430_CR37","unstructured":"Yakun Yu, Xin Wang, Hongxia Wang, et al. Analysis of Influencing Factors in Refractory Rheumatoid Arthritis. Journal of Medical Research, 2023,52(04):36\u201340+82."},{"issue":"05","key":"8430_CR38","first-page":"632","volume":"44","author":"W Yan","year":"2024","unstructured":"Yan W, Yang X, Liu N et al (2024) Research progress on the osteoimmunological mechanisms of bone destruction in rheumatoid arthritis and traditional chinese medicine treatment. Chinese J Integr Traditional Western Med 44(05):632\u2013638","journal-title":"Chinese J Integr Traditional Western Med"},{"issue":"5","key":"8430_CR39","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10067-024-06932-5","volume":"43","author":"N Gupta","year":"2024","unstructured":"Gupta N, Kanwar N, Arora A et al (2024) The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches. Clin Rheumatol 43(5):1421\u20131433","journal-title":"Clin Rheumatol"},{"issue":"1","key":"8430_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13075-024-03432-4","volume":"27","author":"N Luciano","year":"2025","unstructured":"Luciano N, Barone E, Brunetta E et al (2025) Obesity and fibromyalgia are associated with difficult-to-treat rheumatoid arthritis (D2T-RA) independent of age and gender. Arthritis Res Ther 27(1):2","journal-title":"Arthritis Res Ther"},{"key":"8430_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(26)00041-X","author":"W Xie","year":"2026","unstructured":"Xie W, Chen T, Chen Y et al (2026) Associated lifestyle factors and comorbidities of difficult-to-treat rheumatoid arthritis: a systematic review and meta-analysis. Lancet Rheumatol. https:\/\/doi.org\/10.1016\/S2665-9913(26)00041-X","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"8430_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87318-8","volume":"15","author":"M Lesturgie-Talarek","year":"2025","unstructured":"Lesturgie-Talarek M, Gonzalez V, Combier A et al (2025) Inflammatory and angiogenic serum profile of refractory rheumatoid arthritis. Sci Rep 15(1):7159","journal-title":"Sci Rep"},{"issue":"1","key":"8430_CR43","doi-asserted-by":"publisher","first-page":"e001994","DOI":"10.1136\/rmdopen-2021-001994","volume":"8","author":"PC Taylor","year":"2022","unstructured":"Taylor PC, Alten R, \u00c1lvaro GJ et al (2022) Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy. RMD Open 8(1):e001994","journal-title":"RMD Open"},{"issue":"3","key":"8430_CR44","doi-asserted-by":"publisher","first-page":"e004037","DOI":"10.1136\/rmdopen-2023-004037","volume":"10","author":"RF van Vollenhoven","year":"2024","unstructured":"van Vollenhoven RF, Hall S, Wells AF et al (2024) Long-term sustainability of response toupadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND. RMD Open 10(3):e004037","journal-title":"RMD Open"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08430-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:05:37Z","timestamp":1791821137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08430-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":44,"alternative-id":["8430"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08430-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"2 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was reviewed and approved by the Ethics Committee of Dongfang Hospital, Beijing University of Chinese Medicine (Ethics Review No.: JDF-IRB-2024052902). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}